Authors' Reply.
作者信息
Adamsick Meagan L, Bhattacharyya Roby P, Sise Meghan E
机构信息
Division of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts.
Division of Infection Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
出版信息
J Am Soc Nephrol. 2021 Feb 1;32(2):519-520. doi: 10.1681/ASN.2020121692. Epub 2021 Jan 21.
Abstract
摘要
相似文献
1
Authors' Reply.作者回复。
J Am Soc Nephrol. 2021 Feb 1;32(2):519-520. doi: 10.1681/ASN.2020121692. Epub 2021 Jan 21.
2
Aberrations of an IR chopping secondary: authors' reply to comment 2 and continuation of authors' reply to comment 1.红外斩波副镜的像差：作者对评论2的回复以及对评论1回复的延续
Appl Opt. 1985 Apr 1;24(7):944. doi: 10.1364/AO.24.000944.
3
Authors' reply: Comment on authors' reply: Patients' perception of risk: informed choice in prenatal testing for foetal aneuploidy.作者回复：对作者回复的评论：患者对风险的认知：胎儿非整倍体产前检测中的知情选择。
Singapore Med J. 2013 Apr;54(4):238. doi: 10.11622/smedj.2013084.
4
Letter: faecal calprotectin and lactoferrin - accurate biomarkers in post-operative Crohn's disease - authors' reply. Letter: biologic therapies are effective for prevention of post-operative Crohn's disease recurrence - authors' reply.信件：粪便钙卫蛋白和乳铁蛋白——克罗恩病术后的准确生物标志物——作者回复。信件：生物疗法对预防克罗恩病术后复发有效——作者回复。
Aliment Pharmacol Ther. 2014 Aug;40(3):323. doi: 10.1111/apt.12848.
5
Authors' Reply.作者回复。
J Mol Diagn. 2018 Mar;20(2):266. doi: 10.1016/j.jmoldx.2017.12.001.
6
Authors' Reply on: FOCUS more on POCUS.作者对《更多关注床旁超声》的回复
Indian J Crit Care Med. 2023 Mar;27(3):226-227. doi: 10.5005/jp-journals-10071-24428.
7
Authors' Reply.作者回复。
J Mol Diagn. 2018 Jan;20(1):125-126. doi: 10.1016/j.jmoldx.2017.11.002.
8
Authors' Reply: In reply.作者回复：作为回复。
J Trauma Acute Care Surg. 2020 Dec;89(6):e191. doi: 10.1097/TA.0000000000002926.
9
Reply to Senefeld and Hunter: Physiology in Medicine: Neuromuscular consequences of diabetic neuropathy. The authors' reply.对塞内费尔德和亨特的回复：医学中的生理学：糖尿病性神经病变的神经肌肉后果。作者的回复。
J Appl Physiol (1985). 2016 Jul 1;121(1):361. doi: 10.1152/japplphysiol.00423.2016.
10
Editorial: reply to delayed gastric emptying as an independent predictor of mortality in gastroparesis-it is clinically relevant after all! Authors' reply.社论：对胃轻瘫中延迟胃排空作为死亡率独立预测因素的回应——毕竟它具有临床相关性！作者的回应。
Aliment Pharmacol Ther. 2022 Apr;55(8):1048. doi: 10.1111/apt.16885.
引用本文的文献
1
Renal and Hepatic Toxicity Analysis of Remdesivir Formulations: Does What Is on the Inside Really Count?雷米迪维制剂的肾肝毒性分析：内在的东西真的重要吗？
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0104521. doi: 10.1128/AAC.01045-21. Epub 2021 Jul 26.
本文引用的文献
1
Remdesivir in COVID-19 Patients with Impaired Renal Function.瑞德西韦用于肾功能受损的新冠肺炎患者
J Am Soc Nephrol. 2021 Feb 1;32(2):518-519. doi: 10.1681/ASN.2020101535. Epub 2021 Jan 21.
2
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
3
Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m or on Renal Replacement Therapy.接受肾脏替代治疗或估算肾小球滤过率<30 ml/min/1.73m²的患者使用瑞德西韦的情况。
Kidney Int Rep. 2021 Mar;6(3):835-838. doi: 10.1016/j.ekir.2020.11.025. Epub 2020 Nov 27.
4
A Valid Warning or Clinical Lore: an Evaluation of Safety Outcomes of Remdesivir in Patients with Impaired Renal Function from a Multicenter Matched Cohort.有效警示还是临床传闻：多中心匹配队列中肾功能损害患者使用瑞德西韦的安全性结局评估。
Antimicrob Agents Chemother. 2021 Jan 20;65(2). doi: 10.1128/AAC.02290-20.
Zotero 插件